50419-391 : Vitrakvi 100 mg Oral Capsule


NDC50419-391
Labeler: Bayer Healthcare Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Vitrakvi
Dosage Form: Oral Capsule
Application #: NDA210861
Rev. Date: 


NDC Package Codes:

  • 50419-391-01: 60 CAPSULE IN 1 BOTTLE (50419‑391‑01)

Active Ingredients:

  • Larotrectinib

Dosage Strength:

  • 100 mg

Related Products:

Based on records with the same trade name.
  • 50419-390 Vitrakvi 25 mg Oral Capsule by Bayer Healthcare Pharmaceuticals Inc.
  • 50419-392 Vitrakvi 20 mg/ml Oropharyngeal Solution, Concentrate by Bayer Healthcare Pharmaceuticals Inc.
  • 71777-390 Vitrakvi 25 mg Oral Capsule by Loxo Oncology, Inc.
  • 71777-391 Vitrakvi 100 mg Oral Capsule by Loxo Oncology, Inc.
  • 71777-392 Vitrakvi 20 mg/ml Oral Solution by Loxo Oncology, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50419-391 QR Code

< Prev: 50419-390Next: 50419-392 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 August 2019.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA